The assessment of generalized anxiety disorder: psychometric validation of the Spanish version of the self-administered GAD-2 scale in daily medical practice
详细信息 查看全文
- 作者：Javier García-Campayo (1)
Enric Zamorano (2)
Miguel A Ruiz (3)
María Pérez-Páramo (4)
Vanessa López-Gómez (4)
Javier Rejas (5) - 关键词：GAD ; 2 ; Generalised anxiety disorder ; Screening ; Primary care ; Psychometric validity
- 刊名：Health and Quality of Life Outcomes
- 出版年：2012
- 出版时间：December 2012
- 年：2012
- 卷：10
- 期：1
- 全文大小：267KB
- 参考文献：1. Andlin-Sobocki P, Wittchen HU: Cost of affective disorders in Europe. / Eur J Neurol 2005, 12:34-3. CrossRef
2. The ESEMeD/MHEDEA 2000 investigators: Prevalence of mental disorders in Europe: results from the European study of the epidemiology of mental disorders (ESEMeD) project. / Acta Psychiatr Scand 2004, 109:21-7. CrossRef
3. Kroenke K, Spitzer RL, Williams JBW, Monahan PO, L?we B: Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. / Ann Intern Med 2007, 146:317-25.
4. Wittchen HU: Generalized anxiety disorder: Prevalence, burden, and cost to society. / Depress Anxiety 2002, 16:162-71. CrossRef
5. Lobo A: / Campos R Los trastornos de ansiedad en atención primaria. Madrid, EMISA; 1997.
6. Goldberg D, Lecrubier Y: / Form and frequency of mental disorders across centres. Mental illness in general health care: An international study. TB üstün and N Sartorius. John Wiley & Sons on behalf of WHO, Chichester; 1995.
7. Chocrón Bentata L, Vilalta Franch J, Legazpi Rodríguez I, Auquer K, Franch L: Prevalencia de Psicopatología en un centro de atención primaria. / Aten Primaria 1995, 16:586-90.
8. Kessler D, Lloyd K, Lewis G, Gray DP: Cross sectional study of symptom attribution and recognition of depression and anxiety in primary care. / Br Med J 1999, 318:436-39. CrossRef
9. Zimmerman M, Mattia JI: A self-report scale to help make psychiatric diagnoses: the psychiatric diagnostic screening questionnaire. / Arch Gen Psychiatry 2001, 58:787-94. CrossRef
10. American Psychiatric Association: / Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Publishing Inc, Washington DC; 1994.
11. Andrews G, Hobbs MJ, Borkovec TD, Beesdo K, Craske MG, Heimberg RG, Rapee RM, Ruscio AM, Stanley MA: Generalized worry disorder: a review of DSM-IV generalized anxiety disorder and options for DSM-V. / Depress Anxiety 2010, -
12. World Health Organization: / The ICD-10 Classification of mental and behavioral disorders. Clinical descriptions and diagnostic guidelines. WHO, Geneva; 1992.
13. Mahe V, Valgo A: Long-term pharmacological treatment of generalized anxiety disorder. / Int Clin Psychopharmacol 2000, 15:99-05. CrossRef
14. Judd LL, Kessler RC, Paulus MP, Zeller PV, Wittchen HU, Kunovac JL: Comorbidity as a fundamental feature of generalized anxiety disorders: results from the National Comorbidity Study (NCS). / Acta Psychiatr Scan 1998, 393:6-1. CrossRef
15. Stein D: Comorbidity in generalized anxiety disorder: impact and implications. / J Clin Psychiatry 2001, 62:29-6.
16. Hamilton M: Diagnosis and Rating of Anxiety. / Br J Psychiat Spec. Publ 1969, 3:76-9.
17. Zigmond AS, Snaith RP: The hospital anxiety and depression scale. / Acta Psychiatr Scand 1983, 67:361-70. CrossRef
18. Lipman RS, Covi L: Outpatient treatment of neurotic depression: medication and group psychotherapy. In / Evaluation of Psychological Therapies. Edited by: Spitzer R, Klein D. Johns Hopkins University Press, Baltimore, MD; 1976:178-18.
19. Snaith RP, / et al.: The clinical anxiety scale: an instrument derived from the Hamilton anxiety scale. / Br J Psychiatry 1982, 141:518-23. CrossRef
20. Spielberger CD, / et al.: / Manual for the State-Trait Inventory. Consulting Psychological Press, Palo Alto; 1970.
21. Newman M, Zuellig AR, Kachin KE, Constantino MJ, Przeworski A, Erickson T, Cashman-Mcgrath L: Preliminary reliability and validity of the generalized anxiety disorder questionnaire-iv: a revised self-report diagnostic measure of generalized anxiety disorder. / Behav Ther 2002, 33:215-33. CrossRef
22. Kessler RC, Andrews G, Mroczek D, Ustun B, Wittchen HU: The world health organization composite international diagnostic interview short-form (CIDI-SF). / Int J Methods Psychiatr Res 1998, 7:171-85. CrossRef
23. Spitzer RL, / et al.: A brief measure for assessing generalized anxiety disorder. / Arch Intern Med 2006, 166:1092-097. CrossRef
24. García-Campayo JM, Zamorano E, Ruiz MA, Pardo A, Pérez-Páramo M, López-Gómez V, Freire O, Rejas J: Cultural adaptation into spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool. / Health Qual Life Outcomes 2010, 8:8. CrossRef
25. Donker T, van Straten A, Marks I, Cuijpers P: Quick and easy self-rating of generalized anxiety disorder: validity of the dutch web-based GAD-7, GAD-2 and GAD-SI. / Psychiatry Res 2011, 188:58-4. CrossRef
26. Guillemin F, Bombardier C, Beaton D: Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. / J Clin Epidemiol 1993, 46:1417-432. CrossRef
27. Ruiz MA, Rejas J: Calidad de vida y otras medidas de salud informadas por el paciente. In / Farmacoeconomía e investigación de resultados en salud: principios y práctica. Edited by: Domínguez EA, Madrid SJ. Real Academia Nacional de Farmacia, ; 2002:115-60.
28. Nunnally JC, Bernstein IJ: / Teoría Psicométrica (3a ed.). McGraw-Hill, México; 1995.
29. Rovienelli RJ, Hambleton RK: On the use of content specialists in the assessment of criterion-referenced test item validity. / Tijdschrift voor Onderwijsresearch 1977, 1977:49-0.
30. Vázquez-Barquero JL, Vázquez Bourgón E, Herrera Casta?edo S, Saiz J, / et al.: Spanish version of the new World Health Organization Disability Assessment Schedule II (WHO-DAS-II): initial phase of development and pilot study. Cantabria disability work group. / Actas Esp Psiquiatr 2000, 28:77-7.
31. Lowe B, Decker O, Muller S, Brahler E, Schellberg D, Herzog W, / et al.: Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population. / Medical Care 2008, 46:266-74. CrossRef
32. Cronbach LJ: Coefficient alpha and the internal structure of tests. / Psych 1951, 16:297-4.
33. Muthén BO: Latent variable modeling in heterogeneous populations. / Psychometrika 1989, 54:557-86. CrossRef
34. Kano Y: Structural equation modeling for experimental data. In / Structural Equation Modeling: Present and Future. Edited by: Cudeck R, Toit S, S?rbom D. Scientific Software International, Lincolnwood; 2001:381-02.
35. Hanley JA, McNeil BJ: A method of comparing areas under receiver operating characteristic curves defined from the same cases. / Radilogy 1983, 148:839-43.
36. IBM: / IBM SPSS Statistics 19. Chicago IL; 2009.
37. Arbuckle JL, Wothke W: / IBM SPSS AMOS 18. Smallwaters Corporation, Meadville PA; 2009.
38. Zimmerman M, Ruggero CJ, Chelminski I, Young D, Posternak MA, Friedman M, / et al.: Developing brief scales for use in clinical practice: the reliability and validity of single-item self-report measures of depression symptom severity, psychosocial impairment due to depression, and quality of life. / J Clin Psychiatry 2006, 67:1536-541. CrossRef
39. Mitchell AJ, Coyne JC: Do ultra-short screening instruments accurately detect depression in primary care? A pooled analysis and meta-analysis of 22 studies. / Br J Gen Pract 2007, 57:144-51.
40. Watson LC, Zimmerman S, Cohen LW, Dominik R: Practical depression screening in residential care/assisted living: five methods compared with gold standard diagnoses. / Am J Geriatr Psychiatry 2009, 17:556-64. CrossRef
41. Henkel V, Mergl R, Coyne JC, Kohnen R, M?ller HJ, Hegerl U: Screening for depression in primary care: will one or two items suffice? / Eur Arch Psychiatry Clin Neurosci 2004, 254:215-23. CrossRef
42. Donker T, Van Straten A, Marks IM, Cuijpers P: A quick web screening questionnaire for common mental disorders: development and validation. / J Med Internet Res 2009, 11:e19. CrossRef - 作者单位：Javier García-Campayo (1)
Enric Zamorano (2)
Miguel A Ruiz (3)
María Pérez-Páramo (4)
Vanessa López-Gómez (4)
Javier Rejas (5)
1. Department of Psychiatry, Hospital Miguel Servet, Zaragoza, 50009, Spain
2. Primary Care Centre Sant Antoni de Vilamajor, ABS Alt Mogent, Barcelona, Spain
3. Department of Methodology, School of Psychology, Universidad Autónoma de Madrid, Madrid, Spain
4. Medical Unit, Pfizer, S.L.U, Alcobendas, Madrid, Spain
5. Health Economics and Outcomes Research Department, Pfizer, S.L.U, Alcobendas, Madrid, Spain
文摘
Aim To psychometrically validate the Spanish version of the self-administered 2-item GAD-2 scale for screening probable patients with generalised anxiety disorder (GAD). Methods The GAD-2 was self-administered by patients diagnosed with GAD according to DSM-IV criteria and by age- and sex-matched controls who were recruited at random in mental health and primary care centres. Criteria validity was explored using ROC curve analysis, and sensitivity, specificity and positive and negative predictive values were determined for different cut-off values. Concurrent validity was also established using the HAM-A, HADS, and WHODAS II scales. Results The study sample consisted of 212 subjects (106 patients with GAD) with a mean age of 50.38?years (SD--6.76). No items of the scale were left blank. Floor and ceiling effects were negligible. No patients with GAD had to be assisted to complete the questionnaire. Reliability (internal consistency) was high; Cronbach’s α--.875. A cut-off point of 3 showed adequate sensitivity (91.5%) and specificity (85.8%), with a statistically significant area under the curve (AUC--.937, p-lt;-.001), to distinguish GAD patients from controls. Concurrent validity was also high and significant with HAM-A (0.806, p-lt;-.001), HADS (anxiety domain, 0.825, p-lt;-.001) and WHO-DAS II (0.642, p-lt;-.001) scales. Conclusion The Spanish version of the GAD-2 scale has been shown to have appropriate psychometric properties to rapidly detect probable cases of GAD in the Spanish cultural context under routine clinical practice conditions.